Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867243 · ClinicalTrials.gov registry record
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
A clinical trial, sponsored by Northwestern University.
- Terminated
- Registry status
- 24
- Enrollment target
NCT00867243 is a clinical trial that was terminated before completion, run by Northwestern University. The registered enrollment target is 24 participants.
The verdict
NCT00867243 was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to look at cells of the immune system to see if the cells are different among people with different risk factors that have received a liver transplant. We will enroll 50 patients receiving liver transplant and their donors. Both donor and recipient must participate in the order for the recipient to participate in the study. We will take blood samples from these patients and their donors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00867243
The ClinicalTrials.gov registry entry for NCT00867243 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00867243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00867243 about?
NCT00867243 is a clinical study titled "Prediction of Hepatitis C Recurrence in Liver Transplant Recipients". The purpose of the study is to look at cells of the immune system to see if the cells are different among people with different risk factors that have received a liver transplant. We will enroll 50 patients receiving liver transplant and their donors. Both donor and recipient must participate in the...
What is the current status of trial NCT00867243?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2005-10. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00867243?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.